Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes-Reference-Cited by-同舟云学术

Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes

Published:2019-05 Issue:5 Volume:75 Page:817-825
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gandaglia Giorgio,Soligo Matteo,Battaglia Antonino,Muilwijk Tim,Robesti Daniele,Mazzone Elio,Barletta Francesco,Fossati Nicola,Moschini Marco,Bandini Marco,Joniau Steven,Karnes R. Jeffrey,Montorsi Francesco,Briganti Alberto

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

3. Prostate cancer, version 1.2016;Mohler;J Natl Compr Cancer Netw,2016

4. Efficacy of local treatment in prostate cancer patients with clinically pelvic lymph node-positive disease at initial diagnosis;Seisen;Eur Urol,2018

5. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years;Suardi;Eur Urol,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters;European Urology Oncology;2023-09

2. Local Therapy on Clinically Lymph Node–positive Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Oncology;2023-09

3. Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer;EJNMMI Research;2023-07-06

4. Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review;European Urology Oncology;2023-02

5. Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy;In Vivo;2023